Merck KGaA ( MKGAF) - Key Metrics
MKGAF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $12.48 | $1.13 | $1.39 | $0.80 |
| 2026Q1 | $11.85 | $1.52 | $1.89 | $0.84 |
| 2025Q4 | $12.07 | $0.73 | $2.97 | $2 |
| 2025Q3 | $12.20 | $2.07 | $4.09 | $3.07 |
| 2025Q2 | $12.09 | $1.50 | $1.30 | $0.28 |
MKGAF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 208.98% | 32.92 |
| 2026Q1 | 2.12% | 17.42 |
| 2025Q4 | 0% | 43.02 |
| 2025Q3 | 0% | 13.44 |
| 2025Q2 | 43.56% | 18.56 |
MKGAF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.54% | 1.58% |
| 2026Q1 | 0.80% | 0.03% |
| 2025Q4 | 1.60% | 0% |
| 2025Q3 | 2.76% | 0% |
| 2025Q2 | 0.25% | 0.59% |
MKGAF
Price: $154.25
Dividend Yield: 1.65%
Forward Dividend Yield: 1.22%
Payout Ratio: 35.47%
Dividend Per Share: 1.88 USD
Earnings Per Share: 6.74 USD
P/E Ratio: 24.26
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 67.9 billion
Average Dividend Frequency: 1
Years Paying Dividends: 31